Literature DB >> 31874780

Use of polyvinyl alcohol for chimeric antigen receptor T-cell expansion.

Toshinobu Nishimura1, Ian Hsu1, Daniel C Martinez-Krams2, Yusuke Nakauchi2, Ravindra Majeti2, Satoshi Yamazaki3, Hiromitsu Nakauchi4, Adam C Wilkinson5.   

Abstract

Serum albumin has long been an essential supplement for ex vivo hematopoietic and immune cell cultures. However, serum albumin medium supplements represent a major source of biological contamination in cell cultures and often cause loss of cellular function. As serum albumin exhibits significant batch-to-batch variability, it has also been blamed for causing major issues in experimental reproducibility. We recently discovered the synthetic polymer polyvinyl alcohol (PVA) as an inexpensive, Good Manufacturing Practice-compatible, and biologically inert serum albumin replacement for ex vivo hematopoietic stem cell cultures. Importantly, PVA is free of the biological contaminants that have plagued serum albumin-based media. Here, we describe that PVA can replace serum albumin in a range of blood and immune cell cultures including cell lines, primary leukemia samples, and human T lymphocytes. PVA can even replace human serum in the generation and expansion of functional chimeric antigen receptor (CAR) T cells, offering a potentially safer and more cost-efficient approach for this clinical cell therapy. In summary, PVA represents a chemically defined, biologically inert, and inexpensive alternative to serum albumin for a range of cell cultures in hematology and immunology.
Copyright © 2019 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31874780      PMCID: PMC7194120          DOI: 10.1016/j.exphem.2019.11.007

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  12 in total

Review 1.  'Off-the-shelf' immunotherapy with iPSC-derived rejuvenated cytotoxic T lymphocytes.

Authors:  Miki Ando; Hiromitsu Nakauchi
Journal:  Exp Hematol       Date:  2016-11-05       Impact factor: 3.084

2.  A multipotential leukemia cell line (K-562) of human origin.

Authors:  B B Lozzio; C B Lozzio; E G Bamberger; A S Feliu
Journal:  Proc Soc Exp Biol Med       Date:  1981-04

Review 3.  CAR T cell immunotherapy for human cancer.

Authors:  Carl H June; Roddy S O'Connor; Omkar U Kawalekar; Saba Ghassemi; Michael C Milone
Journal:  Science       Date:  2018-03-23       Impact factor: 47.728

4.  Albumin and mammalian cell culture: implications for biotechnology applications.

Authors:  Geoffrey L Francis
Journal:  Cytotechnology       Date:  2010-04-06       Impact factor: 2.058

5.  Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo.

Authors:  Michael C Milone; Jonathan D Fish; Carmine Carpenito; Richard G Carroll; Gwendolyn K Binder; David Teachey; Minu Samanta; Mehdi Lakhal; Brian Gloss; Gwenn Danet-Desnoyers; Dario Campana; James L Riley; Stephan A Grupp; Carl H June
Journal:  Mol Ther       Date:  2009-04-21       Impact factor: 11.454

6.  IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells.

Authors:  Christopher A Klebanoff; Steven E Finkelstein; Deborah R Surman; Michael K Lichtman; Luca Gattinoni; Marc R Theoret; Navrose Grewal; Paul J Spiess; Paul A Antony; Douglas C Palmer; Yutaka Tagaya; Steven A Rosenberg; Thomas A Waldmann; Nicholas P Restifo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

7.  An All-Recombinant Protein-Based Culture System Specifically Identifies Hematopoietic Stem Cell Maintenance Factors.

Authors:  Aki Ieyasu; Reiko Ishida; Takaharu Kimura; Maiko Morita; Adam C Wilkinson; Kazuhiro Sudo; Toshinobu Nishimura; Jun Ohehara; Yoko Tajima; Chen-Yi Lai; Makoto Otsu; Yukio Nakamura; Hideo Ema; Hiromitsu Nakauchi; Satoshi Yamazaki
Journal:  Stem Cell Reports       Date:  2017-02-23       Impact factor: 7.765

Review 8.  Global Manufacturing of CAR T Cell Therapy.

Authors:  Bruce L Levine; James Miskin; Keith Wonnacott; Christopher Keir
Journal:  Mol Ther Methods Clin Dev       Date:  2016-12-31       Impact factor: 6.698

9.  Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6.

Authors:  Rasmus O Bak; Daniel P Dever; Andreas Reinisch; David Cruz Hernandez; Ravindra Majeti; Matthew H Porteus
Journal:  Elife       Date:  2017-09-28       Impact factor: 8.140

Review 10.  Open access? Widening access to chimeric antigen receptor (CAR) therapy for ALL.

Authors:  Sara Ghorashian; Persis Amrolia; Paul Veys
Journal:  Exp Hematol       Date:  2018-07-20       Impact factor: 3.084

View more
  6 in total

Review 1.  Stabilizing hematopoietic stem cells in vitro.

Authors:  Adam C Wilkinson; Hiromitsu Nakauchi
Journal:  Curr Opin Genet Dev       Date:  2020-06-20       Impact factor: 5.578

Review 2.  Haematopoietic stem cell self-renewal in vivo and ex vivo.

Authors:  Adam C Wilkinson; Kyomi J Igarashi; Hiromitsu Nakauchi
Journal:  Nat Rev Genet       Date:  2020-05-28       Impact factor: 53.242

Review 3.  In vivo and ex vivo haematopoietic stem cell expansion.

Authors:  Ryo Yamamoto; Adam C Wilkinson; Hiromitsu Nakauchi
Journal:  Curr Opin Hematol       Date:  2020-07       Impact factor: 3.218

4.  Efficient hepatic differentiation and regeneration potential under xeno-free conditions using mass-producible amnion-derived mesenchymal stem cells.

Authors:  Jiwan Choi; Seoon Kang; Bitnara Kim; Seongjun So; Jongsuk Han; Gyeong-Nam Kim; Mi-Young Lee; Seonae Roh; Ji-Yoon Lee; Soo Jin Oh; Young Hoon Sung; Yeonmi Lee; Sung Hoon Kim; Eunju Kang
Journal:  Stem Cell Res Ther       Date:  2021-11-12       Impact factor: 6.832

Review 5.  Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells.

Authors:  Isabella Maria Mayer; Andrea Hoelbl-Kovacic; Veronika Sexl; Eszter Doma
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

6.  Polyvinyl alcohol hydrolysis rate and molecular weight influence human and murine HSC activity ex vivo.

Authors:  Kazuhiro Sudo; Satoshi Yamazaki; Adam C Wilkinson; Hiromitsu Nakauchi; Yukio Nakamura
Journal:  Stem Cell Res       Date:  2021-09-03       Impact factor: 2.020

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.